Long-term outcomes of refractory Takayasu arteritis patients treated with biologics including ustekinumab
Sign Up to like & getrecommendations! Published in 2020 at "Modern Rheumatology"
DOI: 10.1080/14397595.2020.1800560
Abstract: Abstract Objectives Biologics have been used to treat refractory Takayasu arteritis (TAK), but their efficacy and safety have not been sufficiently evaluated. Methods We extracted clinical information from medical records for TAK patients who were… read more here.
Keywords: takayasu arteritis; refractory takayasu; patients treated; biologics including ... See more keywords